Literature DB >> 34318042

Commentary: Aortic homograft for Warden procedure: Insatiable curiosity.

Fumiya Yoneyama1, Iki Adachi1.   

Abstract

Entities:  

Year:  2020        PMID: 34318042      PMCID: PMC8308262          DOI: 10.1016/j.xjtc.2020.10.032

Source DB:  PubMed          Journal:  JTCVS Tech        ISSN: 2666-2507


× No keyword cloud information.
Fumiya Yoneyama, MD, and Iki Adachi, MD The unique decision to use an aortic homograft represents insatiable curiosity in striving to achieve excellence. An accumulation of such curiosities has formed the fundamental basis of our specialty. See Article page 271. In this issue of the Journal, Kumar and colleagues present a case of a 57-year-old female patient with partial anomalous pulmonary venous return of the right upper and middle pulmonary veins entering the superior vena cava 3 to 4 cm above the cavoatrial junction. To restore the divided superior vena cava and the right atrium, the authors used a non-valved portion of an aortic homograft as an interposition conduit. The authors chose this technique because of the potential benefits of an aortic homograft, such as superior thrombogenicity. In contrast, degenerations and calcifications in the long term remain a matter of concern, as little is known regarding the fate of an aortic homograft in a low-pressure environment. A potential criticism for the reported procedure is whether there was an absolute need for an aortic homograft to achieve the goal of this operation. In general, aortic homografts are precious materials, with limited supply. Availability is one of the key factors that warrant careful consideration when deciding the use of homograft products. This is in stark contrast to that of prosthetic grafts (with essentially unlimited supply), such as expanded polytetrafluoroethylene. Given the lack of need for growth ability in the adult patient, an expanded polytetrafluoroethylene graft would have been a reasonable option in the reported patient. The use of an autologous pericardium has also been suggested previously,, which would likely provide equally favorable thrombogenicity as compared with an aortic homograft. In any operation, there is almost always multiple different options and strategies upon which the surgeon makes a decision based on his/her own preference and philosophy, as well as the patient's unique characteristics. This is particularly the case in congenital heart surgeries, given the wide variations in the anatomical and physiological substrate of the patient's heart. In turn, that would be what makes congenital heart surgeries endlessly attractive, as no heart is the same as another. The unique decision Kumar and colleagues made in their case is an example of insatiable curiosity in striving to achieve excellence. An accumulation of such curiosities would be what has formed the fundamental basis of our specialty over the last several decades.
  3 in total

1.  Modified cavoatrial anastomosis in Warden procedure.

Authors:  Kaiyu Tao; Wencheng Pan; Ke Lin; Yingkang Shi; Peiju Zhu; Yingqiang Guo; Changping Gan; Qi An
Journal:  Ann Thorac Surg       Date:  2010-06       Impact factor: 4.330

2.  Modified Warden procedure for partial anomalous pulmonary venous return to the superior vena cava.

Authors:  Yunfei Ling; Changping Gan; Bhushan Sandeep; Qi An
Journal:  J Card Surg       Date:  2016-08-12       Impact factor: 1.620

3.  Modified Warden operation using aortic homograft.

Authors:  T K Susheel Kumar; David Chen; Dan Halpern; Puneet Bhatla; Sunil Saharan; Michael Argilla; Ralph Mosca
Journal:  JTCVS Tech       Date:  2020-08-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.